Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Muulticenter, Open, Non-interventional, Retrospective Cohort Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

NCT06754865 is registered in ClinicalTrials.gov with Jiangxi Qingfeng Pharmaceutical Co. Ltd. as lead sponsor.

NCT NCT06754865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06754865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Muulticenter, Open, Non-interventional, Retrospective Cohort Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
Lead sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
December 31, 2024
Completion date
November 30, 2025
Enrollment
1,140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of chronic obstructive pulmonary disease